University of Iowa Health Care is looking for volunteers to take part in a national study of a drug that shows promise in the treatment of Alzheimer’s disease. Dr. Del Miller, the UI’s principal investigator for the study, says they’re looking for people between the ages of 50 and 89 who are just starting to show signs of a problem.
UIHC is among nearly 50 sites nationwide taking part in what’s dubbed the BenfoTeam study, which is funded by the National Institutes of Health’s National Institute on Aging. The drug is called benfotiamine and Miller hopes it will slow the symptoms or even reverse them.
Volunteering for the study will involve a commitment of more than a year of visits to Iowa City and Miller says it will not require a lot of invasive procedures.
For more information and to volunteer, call the study coordinator Karen Smith, at 319-353-5158. Alzheimer’s is the sixth-leading cause of death in the United States. In Iowa, more than 62,000 people have been diagnosed with Alzheimer’s or dementia, and there are nearly 100,000 family members and friends caring for their loved ones with the disease. Find our more online at www.benfoteam.org/.
